أعرض في EDS

CLL-532 Changes in Proteome of CLL (Chronic Lymphocytic Leukemia) Lymphocytes During Investigator-Initiated Trial of Ibrutinib Alone and in Combination With Venetoclax in Treatment-Naïve Patients With CLL

التفاصيل البيبلوغرافية
العنوان:	CLL-532 Changes in Proteome of CLL (Chronic Lymphocytic Leukemia) Lymphocytes During Investigator-Initiated Trial of Ibrutinib Alone and in Combination With Venetoclax in Treatment-Naïve Patients With CLL
المؤلفون:	Natalia Timofeeva, Nitin Jain, Ehsan Irajizad, Burcu Aslan, Hiroyuki Katayama, Yining Cai, Mary Ayres, Lakesla Iles, Jody Vykoukal, Jennifer Dennison, Samir Hanash, William Wierda, Varsha Gandhi
المصدر:	Clinical Lymphoma Myeloma and Leukemia. 22:S283
بيانات النشر:	Elsevier BV, 2022.
سنة النشر:	2022
مصطلحات موضوعية:	Cancer Research, Oncology, Hematology
تدمد:	2152-2650
DOI:	10.1016/s2152-2650(22)01355-6
URL الوصول:	https://explore.openaire.eu/search/publication?articleId=doi_________::5c6bc0fd58c2ca0221cce294f1a06694 https://doi.org/10.1016/s2152-2650(22)01355-6
Rights:	CLOSED
رقم الانضمام:	edsair.doi...........5c6bc0fd58c2ca0221cce294f1a06694
قاعدة البيانات:	OpenAIRE

الوصف
تدمد:	21522650
DOI:	10.1016/s2152-2650(22)01355-6